Adderall one of many drugs, medical supplies at risk
Resilinc
NOVEMBER 22, 2022
In October, the FDA announced a shortage of ADHD drug Adderall, with leading manufacturer Teva Pharmaceuticals forecasting that its generic brands would be in short supply until March 2023. But Adderall is by no means the only drug, active pharmaceutical ingredient (API), or medical supply item that is in short supply.
Let's personalize your content